Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gelnova Laboratories is an Indian pharmaceutical formulation and manufacturing company specializing in soft gelatin technology and novel drug delivery systems. Established in 2002 and headquartered in Navi Mumbai, the company is a pioneer in developing patented soft lozenge dosage forms, such as its Novel Gel Delivery System (NGDS) used for sublingual absorption. Gelnova's product portfolio includes soft gelatin capsules, vaginal suppositories, herbal formulations, and its globally patented nicotine pastilles marketed under the brand name Nobacco for smoking cessation. The company operates a WHO-compliant manufacturing facility equipped with multiple encapsulation and lozenge production lines, serving both domestic and international markets as a contract development and manufacturing organization (CDMO).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gelnova Laboratories India.